Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. ESSA Pharma Inc.

    World Rank (Jan-05-2024)
    16,094
    Market Cap (Jan-05-2024)
    0.283 Billion USD
    World Rank (Jul-30-2023)
    20,380
    Market Cap (Jul-30-2023)
    0.128 Billion USD
    World Rank (Dec-25-2022)
    23,440
    Market Cap (Dec-25-2022)
    0.070 Billion USD
    World Rank (Jan-07-2022)
    12,927
    Market Cap (Jan-07-2022)
    0.55 Billion USD
    Headquarters Country
  2. Mersana Therapeutics

    World Rank (Jan-05-2024)
    16,205
    Market Cap (Jan-05-2024)
    0.279 Billion USD
    World Rank (Jul-30-2023)
    19,774
    Market Cap (Jul-30-2023)
    0.144 Billion USD
    World Rank (Dec-25-2022)
    11,492
    Market Cap (Dec-25-2022)
    0.578 Billion USD
    World Rank (Jan-07-2022)
    14,071
    Market Cap (Jan-07-2022)
    0.45 Billion USD
    Annual Revenue in USD
    1 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Mersana Therapeutics is a Biopharmaceutical company specializing in the discovery and development of antibody drug conjugate (ADC) therapies to treat patients fighting cancer. The company total assets is 107.5 million USD as on 2019, total liabilities is 29.2 million USD as on 2019, annual revenue is 42.1 million USD as on 2019 and total equity is 78.3  million USD as on 2019.The headquarters is in USA.
  3. Humacyte Inc.

    World Rank (Jan-05-2024)
    16,215
    Market Cap (Jan-05-2024)
    0.278 Billion USD
    World Rank (Jul-30-2023)
    15,669
    Market Cap (Jul-30-2023)
    0.309 Billion USD
    World Rank (Dec-25-2022)
    17,129
    Market Cap (Dec-25-2022)
    0.237 Billion USD
    World Rank (Jan-07-2022)
    11,893
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -26 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Humacyte is a Clinical Stage Biotechnology Platform company developing universally implantable bioengineered human tissue at a commercial scale with the goal of improving the lives of patients and transforming the practice of medicine. The company total assets are 101 million USD as on 2020. The headquarters is in USA.

  4. TScan Therapeutics Inc.

    World Rank (Jan-05-2024)
    16,349
    Market Cap (Jan-05-2024)
    0.270 Billion USD
    World Rank (Jul-30-2023)
    21,700
    Market Cap (Jul-30-2023)
    0.100 Billion USD
    World Rank (Dec-25-2022)
    26,724
    Market Cap (Dec-25-2022)
    0.036 Billion USD
    World Rank (Jan-07-2022)
    22,171
    Market Cap (Jan-07-2022)
    0.11 Billion USD
    Headquarters Country
  5. Quantum-Si Incorporated

    World Rank (Jan-05-2024)
    16,401
    Market Cap (Jan-05-2024)
    0.268 Billion USD
    World Rank (Jul-30-2023)
    12,912
    Market Cap (Jul-30-2023)
    0.488 Billion USD
    World Rank (Dec-25-2022)
    15,975
    Market Cap (Dec-25-2022)
    0.289 Billion USD
    World Rank (Jan-07-2022)
    10,042
    Market Cap (Jan-07-2022)
    0.89 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -94 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  6. Kamada Ltd.

    World Rank (Jan-05-2024)
    16,409
    Market Cap (Jan-05-2024)
    0.267 Billion USD
    World Rank (Jul-30-2023)
    17,511
    Market Cap (Jul-30-2023)
    0.222 Billion USD
    World Rank (Dec-25-2022)
    18,721
    Market Cap (Dec-25-2022)
    0.176 Billion USD
    World Rank (Jan-07-2022)
    16,794
    Market Cap (Jan-07-2022)
    0.30 Billion USD
    Headquarters Country
  7. Inozyme Pharma Inc.

    World Rank (Jan-05-2024)
    16,447
    Market Cap (Jan-05-2024)
    0.265 Billion USD
    World Rank (Jul-30-2023)
    17,663
    Market Cap (Jul-30-2023)
    0.216 Billion USD
    World Rank (Dec-25-2022)
    25,394
    Market Cap (Dec-25-2022)
    0.048 Billion USD
    World Rank (Jan-07-2022)
    20,454
    Market Cap (Jan-07-2022)
    0.15 Billion USD
    Headquarters Country
    Company Profile
    Inozyme Pharma is a Rare Disease Biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company estimated annual revenue is currently 7.4 million USD per year. The headquarters is in USA.
  8. Esperion Therapeutics

    World Rank (Jan-05-2024)
    16,515
    Market Cap (Jan-05-2024)
    0.262 Billion USD
    World Rank (Jul-30-2023)
    19,737
    Market Cap (Jul-30-2023)
    0.145 Billion USD
    World Rank (Dec-25-2022)
    13,138
    Market Cap (Dec-25-2022)
    0.447 Billion USD
    World Rank (Jan-07-2022)
    17,467
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Revenue in USD
    227 Million USD
    Annual Net Income in USD
    -143 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Esperion Therapeutics is a Pharmaceutical company. The headquarters is in USA.
  9. Heron Therapeutics

    World Rank (Jan-05-2024)
    16,547
    Market Cap (Jan-05-2024)
    0.260 Billion USD
    World Rank (Jul-30-2023)
    18,406
    Market Cap (Jul-30-2023)
    0.187 Billion USD
    World Rank (Dec-25-2022)
    15,577
    Market Cap (Dec-25-2022)
    0.306 Billion USD
    World Rank (Jan-07-2022)
    10,044
    Market Cap (Jan-07-2022)
    0.89 Billion USD
    Annual Revenue in USD
    86 Million USD
    Annual Net Income in USD
    -220 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Heron Therapeutics is a Developing and Commercializing Pharmaceutical Products company. The headquarters is in USA.
  10. Rigel Pharmaceuticals

    World Rank (Jan-05-2024)
    16,563
    Market Cap (Jan-05-2024)
    0.260 Billion USD
    World Rank (Jul-30-2023)
    17,262
    Market Cap (Jul-30-2023)
    0.231 Billion USD
    World Rank (Dec-25-2022)
    17,697
    Market Cap (Dec-25-2022)
    0.213 Billion USD
    World Rank (Jan-07-2022)
    14,363
    Market Cap (Jan-07-2022)
    0.43 Billion USD
    Annual Revenue in USD
    109 Million USD
    Annual Net Income in USD
    -30 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Rigel Pharmaceuticals is a Biotechnology company focused on hematologic disorders, cancer and rare immune diseases. The company annual revenue is 133.9 million USD and 158 employees as on 2020. The headquarters is in USA.

Share

Ads